141 related articles for article (PubMed ID: 36422798)
41. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
Zhao X; Guo X; Shen J; Hua D
Mol Med Rep; 2018 Oct; 18(4):4030-4036. PubMed ID: 30132572
[TBL] [Abstract][Full Text] [Related]
42. Erythropoietin promotes expression of survivin via STAT3 activation and reduces sensitivity to cisplatin in cervical cancer cells.
Vázquez-Mellado MJ; Cortés-Ballinas LG; Blanco-Flores IC; Aguilar C; Vázquez-Gómez G; Rocha-Zavaleta L
Oncol Rep; 2019 Feb; 41(2):1333-1341. PubMed ID: 30483799
[TBL] [Abstract][Full Text] [Related]
43. SiRNA interfering STAT3 enhances DDP sensitivity in cervical cancer cells.
Huang LL; Rao W
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4098-4106. PubMed ID: 30024597
[TBL] [Abstract][Full Text] [Related]
44. Non-nuclear activation of signal transducer and activator of transcription 3 by 17β- estradiol in endometrial cancer cells.
Guo RX; Zhang RF; Wang XY; Li LX; Shi HR; Qiao YH
Neoplasma; 2011; 58(6):532-7. PubMed ID: 21895407
[TBL] [Abstract][Full Text] [Related]
45. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.
Guha P; Gardell J; Darpolor J; Cunetta M; Lima M; Miller G; Espat NJ; Junghans RP; Katz SC
Oncogene; 2019 Jan; 38(4):533-548. PubMed ID: 30158673
[TBL] [Abstract][Full Text] [Related]
46. Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-κB.
Han SZ; Liu HX; Yang LQ; Cui LD; Xu Y
Biomed Pharmacother; 2017 Dec; 96():1403-1410. PubMed ID: 29169726
[TBL] [Abstract][Full Text] [Related]
47. Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer.
Liu C; Feng H; Song L; Li S; Wu Y; Yang L
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 35920185
[TBL] [Abstract][Full Text] [Related]
48. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis.
Morgan EL; Macdonald A
PLoS Pathog; 2019 Jun; 15(6):e1007835. PubMed ID: 31226168
[TBL] [Abstract][Full Text] [Related]
49. LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway.
Guo JL; Tang T; Li JH; Yang YH; Zhang L; Quan Y
Pathol Oncol Res; 2020 Jul; 26(3):1757-1766. PubMed ID: 31650338
[TBL] [Abstract][Full Text] [Related]
50. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
Zhang Z; Wang F; Du C; Guo H; Ma L; Liu X; Kornmann M; Tian X; Yang Y
Cancer Lett; 2017 Aug; 402():213-224. PubMed ID: 28602977
[TBL] [Abstract][Full Text] [Related]
51. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
Saydmohammed M; Joseph D; Syed V
J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
[TBL] [Abstract][Full Text] [Related]
52. Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21.
Yao T; Lu R; Zhang J; Fang X; Fan L; Huang C; Lin R; Lin Z
J Cell Physiol; 2019 Jun; 234(6):9605-9615. PubMed ID: 30352127
[TBL] [Abstract][Full Text] [Related]
53. BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC.
MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
Cancer Lett; 2018 Aug; 428():117-126. PubMed ID: 29653268
[TBL] [Abstract][Full Text] [Related]
54. KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.
Li J; Chen Q; Deng Z; Chen X; Liu H; Tao Y; Wang X; Lin S; Liu N
Life Sci; 2019 May; 224():255-262. PubMed ID: 30928404
[TBL] [Abstract][Full Text] [Related]
55. Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b/STAT3 axis.
Jin XJ; Chen XJ; Zhang ZF; Hu WS; Ou RY; Li S; Xue JS; Chen LL; Hu Y; Zhu H
J Cell Physiol; 2019 May; 234(5):6624-6632. PubMed ID: 30246459
[TBL] [Abstract][Full Text] [Related]
56. Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis.
Kim BG; Yoo JY; Kim TH; Shin JH; Langenheim JF; Ferguson SD; Fazleabas AT; Young SL; Lessey BA; Jeong JW
Hum Reprod; 2015 May; 30(5):1069-78. PubMed ID: 25750101
[TBL] [Abstract][Full Text] [Related]
57. Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation.
Wang JY; Jiang MW; Li MY; Zhang ZH; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Jin HL; Ma J; Jin Y; Zuo HX; Jin X
J Nutr Biochem; 2022 Feb; 100():108899. PubMed ID: 34748924
[TBL] [Abstract][Full Text] [Related]
58. Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
Hossein G; Halvaei S; Heidarian Y; Dehghani-Ghobadi Z; Hassani M; Hosseini H; Naderi N; Sheikh Hassani S
Cancer Med; 2019 Aug; 8(9):4315-4329. PubMed ID: 31197964
[TBL] [Abstract][Full Text] [Related]
59. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.
Shishodia G; Shukla S; Srivastava Y; Masaldan S; Mehta S; Bhambhani S; Sharma S; Mehrotra R; Das BC; Bharti AC
Mol Cancer; 2015 Jun; 14():116. PubMed ID: 26051842
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.
Faried LS; Faried A; Kanuma T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Eur J Cancer; 2006 May; 42(7):934-47. PubMed ID: 16540312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
